¡i©ú³ø±M°T¡jVentas Inc.(¥N¸¹VTR)¤w¹F¨óij¡A¦¬ÁÊBlackstone Group LP(¥N¸¹BX)¦h¶µÂåÀø¤Î¥Í©R¬ì§Þ¾÷ºc¥Îª«·~¡A§@»ù15»õ¬ü¤¸¡C¾Ú©P¤Gµoªíªº¤@¥÷Án©ú»¡¡A¦¹©v¥æ©ö¥]§t¥þ¼ÆÁʤJWexford Science & Technology LLCªº¤j¶q¥Í©R¬ì§Þ¤ÎÂåÀø³]¬Iª«·~¡CWexford¬°¤@®a±Mªù»P¤j¾Ç¡B¾Ç³N©ÊÂåÀø¤¤¤ß¤Î¬ã¨s¾÷ºcµ¥¦X¥óµo®iª«·~ªº¤½¥q¡A¸Ó¤½¥q¬°BioMed Realty Trustªº¦¨û¤§¤@¡A«áªÌ¬OBlackstone©ó¤µ¦~1¤ë¥H48»õ¬ü¤¸¦¬Áʪºª«·~§ë¸ê«H°U(REIT)¡C Ventas¦¬Áʪº¤º®e¬°23¥óª«·~©M¨âÓª«·~µo®i¦a½L¡A¨ä¦í«È¥]¬A¤FC¾|¤j¾Ç¡BWake Forest¤j¾Ç¤ÎÃÄ°ÓAlexion Pharmaceuticals Inc.µ¥¡C¥æ©ö±ø¥ó¤§¤@¬O¡A¦¹REIT»PWexford¹F¦¨¨óij¡A·|¦b¥¼¨Ó¦X§@µo®i·s¦a²£p¹º¡C Ventas¬°¬ü°ê¥«È²Ä¤G¤jÂåÀø«O°·REIT¡A¦b¥þ¬ü°ê¡B¥[®³¤j¤Î^°êµ¥¦a¦X¦@«ù¦³¬ù1,300Óª«·~¡C¨ä¤¤¥]¬A¯Ï^¦í«ÎªÀ°Ï¡BÂåÀø¿ì¤½«Ç«Ø¿v¥H¤Î±M¬ìÂå°|µ¥¡C¤µ¦¸¥æ©ö¼Ð»xþÓ¸Ó¤½¥q¶ix»P¤j¾Ç¾÷ºcÃöÁpªº¥Í©R¬ì§Þ³]¬Iª«·~¡CVentas¤S¦b¤@¥÷Án©ú¤¤»¡¡A±N¥X°â900¸UªÑªÑ²¼¡A¥HѺª`¦¬Áʩһݸêª÷¡C¤µ¦~¥H¨Ó¡AVentasªÑ»ù²ÖpÅD¤É¤F31%¡A»P¦¹¹ï·Ó¡A´^³ÕªºREITÂåÀø«O°·«ü¼Æ¦P´Á¤º¤É´T¬°14%¡CVentasªÑ»ù©P¤G¦¬³ø73.81¬ü¤¸¡A¤É0.61¬ü¤¸¡A©Î0.83%¡C¦Ü¥««á¥æ©ö¡A«h¦^¸¨1.23%¡A©Î0.91¬ü¤¸¡A¦b72.90¬ü¤¸¤ô¥¶R½æ¡C
|
|
|